CD25brightCD4+regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease

Arthritis Research and Therapy

Volumn 6, Issue 4, 2004, Pages

  Cao, Duojia ^a   Vollenhoven, Ronald van ^a   Klareskog, Lars ^a   Trollmo, Christina ^a   Malmström, Vivianne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

autoimmunity; cytokines; human; immune homeostasis; interleukin 17

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTHROPATHY; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; HUMAN; INFLAMMATION; JOINT; JUVENILE RHEUMATOID ARTHRITIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; FEMALE; HUMANS; INFLAMMATION; JOINT DISEASES; JOINTS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RHEUMATIC DISEASES; SPONDYLARTHROPATHIES; T-LYMPHOCYTE SUBSETS;

EID: 15244361536     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1192     Document Type: Article

References (33)

1. Nishizuka Y, Sakakura T: Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science. 1969, 166: 753-755. DOI: 10.1126/science.166.3906.753
2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995, 155: 1151-1164.
3. + regulatory T cells. Nat Immunol. 2003, 4: 330-336. 10.1038/ni904. DOI: 10.1038/ni904
4. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299: 1057-1061. 10.1126/science.1079490. DOI: 10.1126/science.1079490
5. + T regulatory cells. Nat Immunol. 2003, 4: 337-342. 10.1038/ni909. DOI: 10.1038/ni909
6. + regulatory cells that control intestinal inflammation. J Exp Med. 2000, 192: 295-302. 10.1084/jem.192.2.295. DOI: 10.1084/jem.192.2.295
7. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002, 3: 135-142. 10.1038/ni759. DOI: 10.1038/ni759
8. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S: Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999, 162: 5317-5326.
9. Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol. 2001, 31: 1122-1131. 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P. DOI: 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P
10. Li Z, Mahesh SP, Kim BJ, Buggage RR, Nussenblatt RB: Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun. 2003, 21: 83-92. 10.1016/S0896-8411(03)00085-4. DOI: 10.1016/S0896-8411(03)00085-4
11. Ermann J, Fathman CG: Costimulatory signals controlling regulatory T cells. Proc Natl Acad Sci USA. 2003, 100: 15292-15293. 10.1073/pnas.0307001100. DOI: 10.1073/pnas.0307001100
12. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001, 167: 1245-1253. DOI: 10.4049/jimmunol.167.3.1245
13. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C: Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003, 33: 215-223. 10.1002/immu.200390024. DOI: 10.1002/immu.200390024
14. Shevach EM: Regulatory T cells in autoimmmunity. Annu Rev Immunol. 2000, 18: 423-449. 10.1146/annurev.immunol.18.1.423. DOI: 10.1146/annurev.immunol.18.1.423
15. Miossec P: Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 2003, 48: 594-601. 10.1002/art.10816. DOI: 10.1002/art.10816
16. Fink CW: Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol. 1995, 22: 1566-1569.
17. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM: Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998, 25: 1991-1994.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JI, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. DOI: 10.1002/art.1780310302
19. Dauphinee MJ, Dang H, Flescher E, Wilson-Burris K, Galarza D, Hempel K, Talal N: Characterization of the IL-2-receptor on rheumatoid arthritis synovial fluid T cells. J Autoimmun. 1989, 2: 813-824. 10.1016/0896-8411(89)90007-3. DOI: 10.1016/0896-8411(89)90007-3
20. Waalen K, Sioud M, Natvig JB, Forre O: Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes. Scand J Immunol. 1992, 36: 865-873. DOI: 10.1111/j.1365-3083.1992.tb03148.x
21. van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijlsma JW: Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum. 1995, 38: 1466-1474. DOI: 10.1002/art.1780381013
22. + regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001, 2: 301-306. 10.1038/86302. DOI: 10.1038/86302
23. Thornton AM, Shevach EM: Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 2000, 164: 183-190. DOI: 10.4049/jimmunol.164.1.183
24. Costello P, Bresnihan B, O'Farrelly C, FitzGerald O: Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol. 1999, 26: 1117-1124.
25. Kursar M, Bonhagen K, Fensterle J, Kohler A, Hurwitz R, Kamradt T, Kaufmann SH, Mittrucker HW: Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med. 2002, 196: 1585-1592. 10.1084/jem.20011347. DOI: 10.1084/jem.20011347
26. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F: CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med. 2003, 197: 111-119. 10.1084/jem.20021345. DOI: 10.1084/jem.20021345
27. + regulatory T cells control Leishmania major persistence and immunity. Nature. 2002, 420: 502-507. 10.1038/nature01152. DOI: 10.1038/nature01152
28. Black AP, Bhayani H, Ryder CA, Gardner-Medwin JM, Southwood TR: T-cell activation without proliferation in juvenile idiopathic arthritis. Arthritis Res. 2002, 4: 177-183. 10.1186/ar403. DOI: 10.1186/ar403
29. + cells: a naturally occurring population of regulatory T cells. Blood. 2001, 98: 2736-2744. 10.1182/blood.V98.9.2736. DOI: 10.1182/blood.V98.9.2736
30. Wing K, Lindgren S, Kollberg G, Lundgren A, Harris RA, Rudin A, Lundin S, Suri-Payer E: CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur J Immunol. 2003, 33: 579-587. 10.1002/eji.200323701. DOI: 10.1002/eji.200323701
31. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 2003, 299: 1033-1036. 10.1126/science.1078231. DOI: 10.1126/science.1078231
32. Nelson BH: IL-2, regulatory T cells, and tolerance. J Immunol. 2004, 172: 3983-3988. DOI: 10.4049/jimmunol.172.7.3983
33. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W: TGF-beta1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004, 172: 834-842. DOI: 10.4049/jimmunol.172.2.834